Learn more about Paratus — the BARDA Accelerator Network Hub for Digital Health. Click to explore opportunities...

Stories

Stay up to date on all healthcare news from MATTER, Chicago's leading incubator and accelerator.

community

MATTER Shoutouts: August 13, 2018

August 13, 2018

Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look into the most noteworthy happenings from the past few weeks.

ResQ Pharma’s life-saving treatment is within reach. ResQ Pharma has been selected as the first recipient of the Cures Within Reach Impact Award. This $50,000 award will allow ResQ Pha…

Read more

community

MATTER Shoutouts: July 23, 2018

July 23, 2018

Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look inside the most noteworthy happenings from the past few weeks.

Making digital prescriptions easy EazyScripts is “waging war” on handwritten pharmaceutical prescriptions, according to Crain’s Chicago Business. The startup’s technology helps physi…

Read more

community

HabitNu grows up at MATTER, wins CDC recognition for diabetes prevention

July 17, 2018

Like many, HabitNu Founder Sindhu Rajan, PhD, has lost family and friends to diabetes. More than 90 million adults in the U.S. are at risk of developing the disease. Without intervention, 50% of these adults will likely develop diabetes in the next five to seven years.

“I’m a scientist, and researching type 2 diabetes was not a coincidence,” she said.

Before founding HabitNu, Sindhu spent 12 …

Read more

community

MATTER Spotlight: Smit Naik, Actualize Therapy

May 29, 2018

When Smit Naik graduated from the Kellogg School of Management at Northwestern, he knew he wanted to use his new skill sets to bring something life-changing to market. He met Professor David Mohr at Northwestern’s Center for Behavioral Intervention Technologies, and made it his mission to help bring the professor’s research out of the university and into the hands of patients and providers.

Read more

community

MATTER Spotlight: John Colson, ClostraBio

May 9, 2018

ClostraBio is harnessing the protective ability of the microbiome to advance care and improve lives for people with food allergies.

The team has developed a first-of-its kind treatment that utilizes a common class of gut bacteria to act as a barrier, preventing trigger foods from entering the bloodstream and sparking an allergic reaction.

Learn more about ClostraBio

Read more